Pathological mineralization of cardiac valves: Causes and mechanism

Journal of Long-Term Effects of Medical Implants

Volumn 15, Issue 4, 2005, Pages 355-367

  Suvorova, Elena I ^a,c   Buffat, Philippe A ^b  

^a RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^b EPFL   (Switzerland)

^c SHUBNIKOV INSTITUTE OF CRYSTALLOGRAPHY   (Russian Federation)

Author keywords

Calcium phosphates; Crystal morphology and structure; High resolution transmission electron microscopy; Imaging; X ray microanalysis

Indexed keywords

BLOOD VESSELS; CALCIUM COMPOUNDS; CRYSTALS; ELECTRON DIFFRACTION; HIGH RESOLUTION ELECTRON MICROSCOPY; HYDROXYAPATITE; IMAGING TECHNIQUES; NANOSTRUCTURED MATERIALS; PATHOLOGY; SCANNING ELECTRON MICROSCOPY; SOLUTIONS; TRANSMISSION ELECTRON MICROSCOPY; X RAY ANALYSIS;

CALCIUM PHOSPHATES; CRYSTAL MORPHOLOGY AND STRUCTURE; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY (HRTEM); X RAY MICROANALYSIS;

CARDIOLOGY;

CALCIUM PHOSPHATE; COLLAGEN FIBER; HYDROXYAPATITE; MINERAL;

ADULT; AGED; ARTICLE; BONE; CALCIFICATION; CHEMICAL ANALYSIS; CONTROLLED STUDY; CRYSTAL; CRYSTALLOGRAPHY; HEART VALVE; HUMAN; HUMAN TISSUE; MINERALIZATION; PATHOLOGY; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; X RAY MICROANALYSIS;

ADULT; AGED; CALCINOSIS; CALCIUM PHOSPHATES; DURAPATITE; FEMALE; HEART VALVES; HEMODYNAMIC PROCESSES; HUMANS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED;

EID: 24644451106     PISSN: 10506934     EISSN: None     Source Type: Journal    
DOI: 10.1615/JLongTermEffMedImplants.v15.i4.30     Document Type: Article

References (48)

1. Begun PI, Schukeilo YA. Biomechanics. St. Petersburg: Politehnika, 2000.
2. Yoganathan AP. Fluid mechanics of aortic stenosis. Eur Heart J 1988; 9(Suppl E):13-17.
3. Salusky IB, Goodman WG. Cardiovascular calcification in end-stage renal disease. Nephrol Dial Transplant 2002; 17(2):336-339.
4. Locatelli F, Cannata-Andía JB, Drücke TB, Hörl WH, Fouque D, Heimburger O, Ritz E. Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant 2002; 17(5):723-731.
5. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002; 39(4):695-701.
6. 2O) stimulates both chondrogenesis and osteogenesis in the tibia, but only osteogenesis in the parietal bone of a rat. Anatom Rec 1995; 242:40-46.
7. Driessens FC, Boltong MG, de Maeyer EAP, Wenz R, Nies B, Planell JA. The Ca/P range of nanoapatitic calcium phosphate cements. Biomaterials 2002; 23(19):4011-4017.
8. Bohner M, van Landuyt P, Merkle HP, Lemaitre J. Composition effects on the pH of a hydraulic calcium phosphate cement. J Mater Sci Mater Med 1997; 8(11):675-681.
9. Schinke T, Karsenty G. Vascular calcification - a passive process in need of inhibitors. Nephrol Dial Transplant 2000; 15(9):1272-1274.
10. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL. High expression of genes for calcification regulating proteins in human atherosclerotic plaques. J Clin Invest 1994; 93(6):2393-2402.
11. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT. Diffuse calcification in human coronary arteries: association of osteopontin with atherosclerosis. J Clin Invest 1994; 94(4):1597-1604.
12. Shanahan CM, Proudfoot D, Tyson KL, Cary NRB, Edmonds M, Weissberg PL. Expression of mineralization-regulating proteins in association with human vascular calcification. Z Kardiol 2000; 89(Suppl 2):63-68.
13. Wallin R, Wajih N, Greenwood GT, Sane DC. Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy. Med Res Rev 2001; 21(4):274-301.
14. Boskey AL, Posner AS. Formation of hydroxyapatite at low supersaturation. J Phys Chem 1976; 80(1):40-45.
15. Moreno ES, Zahradnic RT, Glazman A, Hwu R. Precipitation of hydroxyapatite from dilute solutions upon seeding. Calcif Tiss Int 1977; 24:47-57.
16. Moreno ES, Varughese K. Crystal growth of calcium apatites from dilute solutions. J Cryst Growth 1981; 53:20-30.
17. Kapolos J, Mavrilas D, Missirlis Y, Koutsoukos PG. Model experimental system for investigation of heart valve calcification in vitro. J Biomed Mater Res 1997; 38(3):183-190.
18. Lundager Madsen HE, Christensson F, Polyak LE, Suvorova EI, Kliya MO, Chernov AA. Calcium phosphate crystallization under terrestrial and microgravity conditions. J Cryst Growth 1995; 152(3):191-202.
19. Suvorova EI, Christensson F, Lundager Madsen HE, Chernov AA. Terrestrial and space-grown HAP and OCP crystals: effect of growth conditions on perfections and morphology. J Cryst Growth 1998; 186(1-2):262-274.
20. Titov AT, Larionov PM, Shchukin VS, Zaikovskii VI. Possible formation of hydroxyapatite in blood. Doklady Biochemistry 2000; 373:132-134.
21. De Hart J, Peters GW, Schreurs PJ, Baaijens FP. A three dimensional computational analysis of fluid-structure interaction in the aortic valve. J Biomech 2003; 36(1):103-112.
22. De Hart J, Cacciola G, Schreurs PJ, Peters GW. A three dimensional analysis of a fibre-reinforced aortic valve prosthesis. J Biomech 1998; 31(7):629-638.
23. Lim WL, Chew YT, Chew TC, Low HT. Pulsatile flow studies of a porcine bioprosthetic aortic valve in vitro: PIV measurements and shear-induced blood damage. J Biomech 2001; 34(11):1417-1427.
24. Schoen F, Levy R. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res 1999; 47(4):439-65.
25. Suvorova EI, BufFat PA. Electron diffraction and high-resolution transmission electron microscopy in characterization of calcium phosphate precipitation from aqueous solutions under biomineralization conditions. Eur Cell Mater 2001; 1:27-42.
26. Suvorova EI, Buffat PA. Model of the mechanism of Ca loss by bones under microgravity and earth conditions. J Biomed Mater Res 2002; 63(4):424-432.
27. Suvorova EI, Buffat PA. Electron diffraction from micro- and nanoparticles of hydroxyapatite. J Microsc 1999; 196(1):46-58.
28. Suvorova EI, Buffat PA. Size effect in X-ray and electron diffraction patterns from hydroxyapatite particles. Crystallogr Rep 2001; 46(5):722-729.
29. Inorganic Crystal Structure Database (ICSD), FIZ Karlsruhe, Germany and NIST, U.S. Department of Commerce, version 1.3.1,2003. Code # 133,10503, 1912,2632,6191,16738,22059,34457,65347,923, 200202,73712,22225.
30. Stadelmann P. JEMS, http://cimewww.epfl.ch/ people/Stadelmann/ jemsWebSite/jems.html
31. Suvorova EI, Stadelmann PA, Buffat PA. HRTEM simulation in determination of thickness and grain misorientation for hydroxyapatite crystals. Crystallogr Rep 2004; 49(3):343-352.
32. Chernov AA. Modern Crystallography III. Crystal Growth. Berlin: Springer-Verlag, 1984.
33. Bałdyga J, Bourne JR. Turbulent mixing and chemical reactions. Chichester: Wiley, 1999.
34. Ganong WF. Review of Medical Physiology. 21 ed. New York: McGraw-Hill, 2003.
35. Moreno EC, Gregory TM, Brown WE. Preparation and solubility of hydroxyapatite. J Res Nat Bur Stand A Phys Chem 1968; 72:773-782.
36. Moreno EC, Brown WE, Osborn G. Stability of dicalcium phosphate dehydrate in aqueous solutions and solubility product of octacalcium phosphate. Soil Sci Soc Am Proc 1960; 24:99-102.
37. Ventura JE, Tavella N, Romero C, Petraglia A, Báez A, Muñoz L. Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenance haemodialysis. Nephrol Dial Transplant 2002; 17(10):1795-1801.
38. Guérin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15(7):1014-1021.
39. Chertow GM. Slowing the progression of vascular calcification in hemodialysis. J Am Soc Nephrol 2003; 14(9 Suppl 4):S310-314.
40. Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddahi J, Rumberger J, Stanford W, White R, Taubert K. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. Circulation 1996; 94(5):1175-1192.
41. Mohler ER, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001; 103(11):1522-1528.
42. Bini A, Mann KG, Kudryk BJ, Schoen FJ. Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 1999; 19(8):1852-1861.
43. Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan D, Springett M, Orszulak T, Fullerton DA, Tajik AJ, Bonow RO, Spelsberg T. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003; 107(17):2181-2184.
44. Shen M, Marie P, Farge D, Carpentier S, Pollak C, Hott M, Chen L, Martinet B, Carpentier A. Osteopontin is associated with bioprosthetic heart valve calcification in humans. CR Acad Sci III. 1997; 320(1):49-57.
45. Bacon GE. The study of bones by neutron diffraction. J Appl Cryst 1977; 10:124-126.
46. Sato K, Kogure T, Kumagai Y, Tanaka J. Crystal orientation of hydroxyapatite induced by ordered carboxyl groups. J Colloid Interface Sci 2001; 240(1):133-138.
47. Sato K, Kumagai Y, Tanaka J. Apatite formation on organic monolayers in simulated body environment. J Biomed Mater Res 2000; 50(1):16-20.
48. Tong W, Eppell SJ. Control of surface mineralization using collagen fibrils. J Biomed Mater Res 2002; 61(3):346-353.